Payment overview · 2025
General Payments
$131.15
6 reported records · 4 companies
Healthcare provider profile · identity verified
Quadir Jaleel, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · HAMTRAMCK, MI · NPI 1225016256
Verified facts
What the public records show
CMS Open Payments records show Quadir Jaleel, M.D. received $131.15 in general payments during 2025 across 6 reported records.
Novo Nordisk Inc accounted for 38.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rybelsus.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 57 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Linzess by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 138 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 19 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $51.02 | 38.9% | 2 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $39.78 | 30.3% | 2 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $23.24 | 17.7% | 1 | 2025 |
| Aimmune Therapeutics, Inc. | Unresolved — no canonical attribution shown | $17.11 | 13.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $131.15 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $51.02 | 2 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $51.02 | 2 | 2025 |
Source payment records
|
|||||
| COLLAGENASE SANTYL Normalized: collagenase santyl |
Drug | Smith+Nephew, Inc. | $39.78 | 2 | 2025 |
Source payment records
|
|||||
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $23.24 | 1 | 2025 |
Source payment records
|
|||||
| ZENPEP Normalized: zenpep |
Drug | Aimmune Therapeutics, Inc. | $17.11 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 138 | exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 19 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
57 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
138 | 21 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
19 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1824 | 298 |
| Amlodipine Besylate | Amlodipine Besylate | 977 | 152 |
| Pantoprazole Sodium | Pantoprazole Sodium | 953 | 181 |
| Losartan Potassium | Losartan Potassium | 702 | 119 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 680 | 109 |
| Hydralazine Hcl | Hydralazine Hcl | 640 | 108 |
| Metoprolol Succinate | Metoprolol Succinate | 618 | 109 |
| Nifedipine Er | Nifedipine | 582 | 86 |
| Carvedilol | Carvedilol | 537 | 82 |
| Fluticasone Propionate | Fluticasone Propionate | 507 | 115 |
| Furosemide | Furosemide | 488 | 86 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 475 | 102 |
| Potassium Chloride | Potassium Chloride | 451 | 87 |
| Lactulose | Lactulose | 416 | 97 |
| Eliquis | Apixaban | 386 | 61 |
| Tamsulosin Hcl | Tamsulosin Hcl | 382 | 66 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 369 | 90 |
| Gabapentin | Gabapentin | 340 | 73 |
| Levothyroxine Sodium | Levothyroxine Sodium | 339 | 55 |
| Metformin Hcl | Metformin Hcl | 309 | 52 |
| Metoprolol Tartrate | Metoprolol Tartrate | 296 | 54 |
| Clopidogrel | Clopidogrel Bisulfate | 285 | 55 |
| Lisinopril | Lisinopril | 271 | 49 |
| Escitalopram Oxalate | Escitalopram Oxalate | 247 | 40 |
| Levetiracetam | Levetiracetam | 240 | 31 |
| Breo Ellipta | Fluticasone/Vilanterol | 206 | 46 |
| Sertraline Hcl | Sertraline Hcl | 202 | 34 |
| Famotidine | Famotidine | 199 | 40 |
| Spironolactone | Spironolactone | 192 | 28 |
| Celecoxib | Celecoxib | 184 | 45 |
| Alprazolam | Alprazolam | 182 | 41 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 181 | 45 |
| Chlorthalidone | Chlorthalidone | 180 | 30 |
| Glipizide Er | Glipizide | 171 | 32 |
| Hydrocortisone | Hydrocortisone | 169 | 39 |
| Diclofenac Sodium | Diclofenac Sodium | 161 | 44 |
| Oxycodone Hcl | Oxycodone Hcl | 155 | 26 |
| Buspirone Hcl | Buspirone Hcl | 153 | 25 |
| Ezetimibe | Ezetimibe | 152 | 20 |
| Omeprazole | Omeprazole | 150 | 30 |
| Ventolin Hfa | Albuterol Sulfate | 149 | 47 |
| Allopurinol | Allopurinol | 148 | 27 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 147 | 26 |
| Prednisone | Prednisone | 145 | 53 |
| Alendronate Sodium | Alendronate Sodium | 144 | 19 |
| Trazodone Hcl | Trazodone Hcl | 142 | 21 |
| Olanzapine | Olanzapine | 139 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 138 | 32 |
| Ozempic | Semaglutide | 138 | 21 |
| Divalproex Sodium | Divalproex Sodium | 133 | 20 |
| Baclofen | Baclofen | 131 | 26 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 128 | 24 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 127 | 35 |
| Mirtazapine | Mirtazapine | 120 | 26 |
| Bumetanide | Bumetanide | 119 | 21 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 116 | 28 |
| Risperidone | Risperidone | 112 | suppressed |
| Finasteride | Finasteride | 106 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 106 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 104 | 22 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 102 | 19 |
| Xarelto | Rivaroxaban | 102 | 24 |
| Tramadol Hcl | Tramadol Hcl | 96 | 35 |
| Latanoprost | Latanoprost | 91 | 18 |
| Novolog Flexpen | Insulin Aspart | 90 | 27 |
| Amiodarone Hcl | Amiodarone Hcl | 89 | 13 |
| Midodrine Hcl | Midodrine Hcl | 85 | 18 |
| Clonidine | Clonidine | 84 | 15 |
| Cilostazol | Cilostazol | 83 | 12 |
| Donepezil Hcl | Donepezil Hcl | 82 | 14 |
| Methocarbamol | Methocarbamol | 82 | 22 |
| Hydrochlorothiazide | Hydrochlorothiazide | 81 | 12 |
| Jardiance | Empagliflozin | 81 | 20 |
| Azithromycin | Azithromycin | 80 | 53 |
| Entresto | Sacubitril/Valsartan | 80 | suppressed |
| Pregabalin | Pregabalin | 77 | 18 |
| Incruse Ellipta | Umeclidinium Bromide | 76 | 19 |
| Lorazepam | Lorazepam | 75 | 22 |
| Ondansetron Hcl | Ondansetron Hcl | 75 | 29 |
| Clonidine Hcl | Clonidine Hcl | 73 | 13 |
| Doxycycline Hyclate | Doxycycline Hyclate | 72 | 42 |
| Duloxetine Hcl | Duloxetine Hcl | 71 | 19 |
| Montelukast Sodium | Montelukast Sodium | 71 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 70 | 19 |
| Lidocaine | Lidocaine | 69 | 20 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 65 | 20 |
| Farxiga | Dapagliflozin Propanediol | 64 | 17 |
| Ranolazine Er | Ranolazine | 64 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 63 | 14 |
| Symbicort | Budesonide/Formoterol Fumarate | 62 | 23 |
| Easy Touch Alcohol Prep Pads | Alcohol Antiseptic Pads | 60 | 22 |
| Januvia | Sitagliptin Phosphate | 58 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 58 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 57 | 11 |
| Creon | Lipase/Protease/Amylase | 57 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 57 | 21 |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 57 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 55 | 18 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 55 | 12 |
| Oxybutynin Chloride | Oxybutynin Chloride | 55 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 55 | suppressed |
| Constulose | Lactulose | 53 | 15 |
| Nitroglycerin | Nitroglycerin | 53 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 53 | suppressed |
| Aripiprazole | Aripiprazole | 51 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 51 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 51 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 50 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 49 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 49 | 13 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 48 | suppressed |
| Topiramate | Topiramate | 47 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 46 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 46 | 12 |
| Haloperidol | Haloperidol | 45 | suppressed |
| Lacosamide | Lacosamide | 45 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 43 | 29 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 43 | suppressed |
| Admelog Solostar | Insulin Lispro | 42 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 42 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 42 | 30 |
| Brimonidine Tartrate | Brimonidine Tartrate | 41 | suppressed |
| Ibuprofen | Ibuprofen | 40 | 18 |
| Timolol Maleate | Timolol Maleate | 40 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 39 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 39 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 38 | 27 |
| Loperamide | Loperamide Hcl | 38 | suppressed |
| Simvastatin | Simvastatin | 38 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 38 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 37 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 36 | 13 |
| Glipizide | Glipizide | 35 | suppressed |
| Tradjenta | Linagliptin | 35 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 34 | suppressed |
| Gemtesa | Vibegron | 34 | suppressed |
| Nystatin | Nystatin | 34 | 15 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 34 | 16 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 34 | 11 |
| Colchicine | Colchicine | 32 | suppressed |
| Ketoconazole | Ketoconazole | 32 | suppressed |
| Atenolol | Atenolol | 31 | suppressed |
| Fluconazole | Fluconazole | 31 | 20 |
| Humalog Kwikpen U-100 | Insulin Lispro | 31 | 11 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 31 | suppressed |
| Amoxicillin | Amoxicillin | 30 | 14 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 30 | 15 |
| Divalproex Sodium Er | Divalproex Sodium | 29 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 28 | 15 |
| Bicalutamide | Bicalutamide | 28 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 28 | 12 |
| Sucralfate | Sucralfate | 28 | 15 |
| Enalapril Maleate | Enalapril Maleate | 27 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 27 | suppressed |
| Metolazone | Metolazone | 27 | suppressed |
| Clonazepam | Clonazepam | 26 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 26 | 12 |
| Insulin Lispro | Insulin Lispro | 25 | suppressed |
| Myrbetriq | Mirabegron | 25 | suppressed |
| Novolog | Insulin Aspart | 24 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 24 | suppressed |
| Digoxin | Digoxin | 23 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 23 | 12 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 23 | suppressed |
| Nyamyc | Nystatin | 23 | suppressed |
| Ondansetron Odt | Ondansetron | 23 | 12 |
| Caplyta | Lumateperone Tosylate | 22 | suppressed |
| Verapamil Er | Verapamil Hcl | 22 | suppressed |
| Bupropion Xl | Bupropion Hcl | 21 | suppressed |
| Mupirocin | Mupirocin | 21 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 20 | suppressed |
| Calcium Acetate | Calcium Acetate | 20 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Enulose | Lactulose | 20 | suppressed |
| Minoxidil | Minoxidil | 20 | suppressed |
| Nicardipine Hcl | Nicardipine Hcl | 20 | suppressed |
| Single Use Swab | Alcohol Antiseptic Pads | 20 | 11 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | suppressed |
| Acetazolamide | Acetazolamide | 19 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 19 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 19 | suppressed |
| Rybelsus | Semaglutide | 19 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 19 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 19 | suppressed |
| Alcohol Swabs | Alcohol Antiseptic Pads | 18 | suppressed |
| Brilinta | Ticagrelor | 18 | suppressed |
| Carbamazepine | Carbamazepine | 18 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 18 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 18 | suppressed |
| Meloxicam | Meloxicam | 18 | suppressed |
| Memantine Hcl | Memantine Hcl | 18 | suppressed |
| Methylprednisolone | Methylprednisolone | 18 | 16 |
| Nitroglycerin Patch | Nitroglycerin | 18 | suppressed |
| Nystop | Nystatin | 18 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 17 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 17 | suppressed |
| Cephalexin | Cephalexin | 17 | 11 |
| Clindamycin Phosphate | Clindamycin Phosphate | 17 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 17 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 17 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 16 | suppressed |
| Ofloxacin | Ofloxacin | 16 | 11 |
| Varenicline Tartrate | Varenicline Tartrate | 16 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 15 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 15 | suppressed |
| Irbesartan | Irbesartan | 15 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 15 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 15 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 15 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 15 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Sure Comfort Alcohol | Alcohol Antiseptic Pads | 15 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 14 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | suppressed |
| Naproxen | Naproxen | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 14 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 13 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 13 | suppressed |
| Letrozole | Letrozole | 13 | suppressed |
| Acyclovir | Acyclovir | 12 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 12 | suppressed |
| Diazepam | Diazepam | 12 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 12 | suppressed |
| Estradiol | Estradiol | 12 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 12 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 12 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | suppressed |
| Ertapenem | Ertapenem Sodium | 11 | suppressed |
| Humira(Cf) Pen | Adalimumab | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 11 | suppressed |
| Westab Plus | Pnv,calcium 72/Iron/Folic Acid | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $131.15 · 6 records | Novo Nordisk Inc | COLLAGENASE SANTYL, Ozempic, Rybelsus, VRAYLAR, ZENPEP | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error